Abstract
Paget–Schroetter syndrome due to thoracic outlet syndrome is a rare but potentially disabling condition that generally affects young patients otherwise healthy. The prompt diagnosis and treatment of Paget–Schroetter syndrome is necessary to avoid major morbidity and long-term disability. The more modern treatment paradigm reported in the current literature consists of hybrid procedures with surgical decompression of the thoracic outlet and endovascular techniques to potentially improve long-term vein patency. However, there seems to be no consensus in the literature with regard to the timing and precise nature of active management, and there is presently no agreed protocol for the optimum management of Paget–Schroetter syndrome. Controversy exists partly because no randomised controlled studies are present in literature. We present a case of Paget–Schroetter syndrome due to thoracic outlet syndrome in a young male patient submitted to a multimodal procedure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hurlbert SN, Rutherford RB. Basic data underlying clinical decision making—primary subclavian-axillary vein thrombosis. Ann Vasc Surg. 1995;9:217–23.
Donayre CE, White GH, Mehringer SM, Wilson SE. Pathogenesis determines late morbidity of axillosubclavian vein thrombosis. Am J Surg. 1986;152:179–84.
Lee JT, Karwowski JK, Harris EJ, Haukoos JS, Olcott C 4th. Long-term thrombotic recurrence after nonoperative management of Paget–Schroetter syndrome. J Vasc Surg. 2006;43(6):1236–43.
Schneider DB, Dimuzio PJ, Martin ND, Gordon RL, Wilson MW, Laberge JM, et al. Combination treatment of venous thoracic outlet syndrome (open surgical decompression and intraoperative angioplasty). J Vasc Surg. 2004;40:599–603.
Machleder HI. Evaluation of a new treatment strategy for Paget–Schroetter syndrome (spontaneous thrombosis of the axillary-subclavian vein). J Vasc Surg. 1993;17:305–17.
Kreienberg PB, Chang BB, Darling RC, Roddy SP, Paty PSK, Lloyd WE, et al. Long-term results in patients treated with thrombolysis, thoracic inlet decompression, and subclavian vein stenting for Paget–Schroetter syndrome. J Vasc Surg. 2001;33:S100–5.
Rutherford RB. Primary subclavian-axillary vein thrombosis: the relative roles of thrombolysis, percutaneous angioplasty, stents, and surgery. Semin Vasc Surg. 1998;11:91–5.
Lee MC, Grassi CJ, Belkin JA, Whittemore AD, Donaldson MC. Early operative intervention after thrombolytic therapy for primary subclavian vein thrombosis: an effective treatment approach. J Vasc Surg. 1998;27:1101–8.
Pupka A, Szyber PP, Garcarek J, Szyber P. The use of intravascular nitinol stents in the treatment of subclavian vein compression for thoracic outlet syndrome. Polim Med. 2007;37(2):51–5.
Coletta JM, Murray JD, Reeves TR, Velling TE, Brennan FJ, Hemp JR, Hall LD. Vascular thoracic outlet syndrome: successful outcomes with multimodal therapy. Cardiovasc Surg. 2001;9(1):11–5.
Conflict of interest
The authors have declared that no conflict of interest exists.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De Caridi, G., Massara, M., Greco, M. et al. Hybrid management of Paget–Schroetter syndrome due to thoracic outlet syndrome. Gen Thorac Cardiovasc Surg 64, 109–112 (2016). https://doi.org/10.1007/s11748-014-0445-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-014-0445-3